NarrativeContentItem

The text of a section, as XHTML. This is where the prose of the protocol lives next to the structured design.

Kind
Concrete class
Attributes
5, 4 required
NCI code
C215489

Official definition

An individual item within the container that holds an instance of unstructured text and which may include objects such as tables, figures, and images.
Narrative Content Item, CDISC USDM 4.0, NCI C215489

In practice

In a protocol document: The body text under a section heading.

Attributes

5 attributes, 4 of them required by the USDM API schema.

AttributeTypeCard.Definition
idrequiredstringcardinality 1The identifier of this object, unique within the file.
namerequiredstringcardinality 1The literal identifier (i.e., distinctive designation) of the narrative content item.
textrequiredstringcardinality 1An instance of unstructured text that represents the narrative content item.
extensionAttributesExtensionAttributecardinality 0..*Extension attributes attached to this object, for information the standard does not define. Added by the API; not part of the logical model.
instanceTyperequiredstringcardinality 1The name of the class, carried by every object in a USDM JSON file. Added by the API; not part of the logical model.

Smallest valid NarrativeContentItem

The attributes a JSON file must carry for a NarrativeContentItem, and the kind of value each takes. This is the shape, with types named in place of values. Everything else in the table above is optional.

NarrativeContentItem, required attributes only
{
  "id": "NarrativeContentItem_1",
  "name": string,
  "text": string,
  "instanceType": "NarrativeContentItem"
}

Where NarrativeContentItem is used

These classes hold or point to a NarrativeContentItem.

Example

A NarrativeContentItem from the example study. Coded values are shortened to one line.

NarrativeContentItem_1
{
  "id": "NarrativeContentItem_1",
  "name": "OVERALL_DESIGN_TEXT",
  "text": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This is a multicentre, randomized, double-blind, placebo-controlled, parallel-group study. Approximately 120 participants are randomized 1:1 to EX-101 10 mg or placebo once daily for 12 weeks.</p></div>",
  "instanceType": "NarrativeContentItem"
}

Other classes in documents and narrative:

← All 86 classes